Scancell Holdings (PLUS: SCLP) - differentiated technology and a focused plan offer ingredients for success
PLUS: SCLP
Coverage by Objective Capital
Questions?
|
(32 pages, this is a 1.3M download)
Scancell Holdings (AIM: SCLP) - action set to accelerate trial enrollment
Feb 04, 2011
| Click for PDF
Scancell Holdings (AIM: SCLP) - thesis intact, but trial enrollment slow going
Dec 16, 2010
Scancell Holdings (PLUS: SCLP) - Scancell continues to fire on all cylinders
Oct 13, 2010
| Click for PDF
Scancell Holdings (PLUS: SCLP) - bolt-on value with new licensing agreement
Aug 10, 2010
Scancell Holdings (SCLP.PLUS) - year-end results and move to AIM listing
Jul 15, 2010
Scancell Holdings (SCLP.PLUS) -Link Up With European Leader in Cutting Edge Immunotherapy Technology
Jul 02, 2010
Scancell Holdings (SCLP.PLUS) - the beat goes on as visibility increases
May 21, 2010
Scancell Holdings (SCLP.PLUS) - fully-underwritten offering to net £2.3m
Mar 09, 2010
Scancell Holdings (SCLP.PLUS) - still on track for initiation of clinical trials in Q2
Feb 05, 2010
Scancell Holdings (SCLP.PLUS) - "steady as she goes"
Dec 22, 2009
| Click for PDF
Scancell Holdings (SCLP.PLUS) - differentiated technology and a focused plan offer ingredients for success
Sep 08, 2009
| Click for PDF